1. Home
  2. NTRA
  3. NTRA News

Latest Natera Inc. (NTRA) News on July 2, 2025

Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target
NTRA

Insider Monkey

8 days ago

Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks
NTRA

StockStory

9 days ago

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

3 Reasons We Love Natera (NTRA)
NTRA

StockStory

12 days ago

3 Reasons We Love Natera (NTRA)

High Growth US Tech Stocks To Watch In June 2025
NTRA

Simply Wall St.

13 days ago

High Growth US Tech Stocks To Watch In June 2025

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase
NTRA

StockStory

22 days ago

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase

NTRA

MT Newswires

a month ago

Natera Says Signatera Cancer Test Approved for Medicare Coverage

Natera Announces Medicare Coverage for Signatera™ Genome
NTRA

Business Wire

a month ago

Natera Announces Medicare Coverage for Signatera™ Genome

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study
NTRA

Simply Wall St.

a month ago

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025
NTRA

Business Wire

a month ago

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025

3 Mid-Cap Stocks Worth Your Attention
NTRA

StockStory

a month ago

3 Mid-Cap Stocks Worth Your Attention

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting
NTRA

Business Wire

a month ago

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting

Exploring 3 High Growth Tech Stocks In The US Market
NTRA

Simply Wall St.

a month ago

Exploring 3 High Growth Tech Stocks In The US Market

3 Stocks That May Be Trading Below Their Estimated Value
NTRA

Simply Wall St.

a month ago

3 Stocks That May Be Trading Below Their Estimated Value

Natera, Inc. (NTRA): A Bull Case Theory
NTRA

Insider Monkey

2 months ago

Natera, Inc. (NTRA): A Bull Case Theory

Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
NTRA

Simply Wall St.

2 months ago

Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Natera First Quarter 2025 Earnings: Beats Expectations
NTRA

Simply Wall St.

2 months ago

Natera First Quarter 2025 Earnings: Beats Expectations

NTRA

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Natera Inc Earnings Call

Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance
NTRA

GuruFocus.com

2 months ago

Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
NTRA

Zacks

2 months ago

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales
NTRA

StockStory

2 months ago

Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales

NTRA

Associated Press Finance

2 months ago

Natera: Q1 Earnings Snapshot

Natera Reports First Quarter 2025 Financial Results
NTRA

Business Wire

2 months ago

Natera Reports First Quarter 2025 Financial Results

Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress
NTRA

Business Wire

2 months ago

Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress

Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings
NTRA

GuruFocus.com

2 months ago

Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings

Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows
NTRA

Business Wire

2 months ago

Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows

What To Expect From Natera’s (NTRA) Q1 Earnings
NTRA

StockStory

2 months ago

What To Expect From Natera’s (NTRA) Q1 Earnings

Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas
NTRA

Medical Device Network

2 months ago

Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
NTRA

Business Wire

2 months ago

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Natera to Report its First Quarter Results on May 8, 2025
NTRA

Business Wire

2 months ago

Natera to Report its First Quarter Results on May 8, 2025

Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study
NTRA

Simply Wall St.

2 months ago

Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction
NTRA

Business Wire

2 months ago

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
NTRA

StockStory

2 months ago

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
NTRA

StockStory

2 months ago

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now
NTRA

Insider Monkey

2 months ago

Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
NTRA

Business Wire

2 months ago

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
NTRA

Business Wire

2 months ago

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
NTRA

Investor's Business Daily

2 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value
NTRA

Simply Wall St.

3 months ago

3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
NTRA

StockStory

3 months ago

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

High Growth Tech Stocks In US With Potential For Expansion
NTRA

Simply Wall St.

3 months ago

High Growth Tech Stocks In US With Potential For Expansion

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
NTRA

StockStory

3 months ago

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

Natera (NasdaqGS:NTRA) Climbs 11% in One Week
NTRA

Simply Wall St.

3 months ago

Natera (NasdaqGS:NTRA) Climbs 11% in One Week

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?
NTRA

Simply Wall St.

3 months ago

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love
NTRA

Insider Monkey

3 months ago

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love

3 Reasons NTRA Has Explosive Upside Potential
NTRA

StockStory

3 months ago

3 Reasons NTRA Has Explosive Upside Potential

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
NTRA

Motley Fool

3 months ago

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
NTRA

StockStory

3 months ago

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
NTRA

Business Wire

3 months ago

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?
NTRA

Insider Monkey

3 months ago

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?

Here’s What Lifted Natera (NTRA) in Q4 and 2024
NTRA

Insider Monkey

3 months ago

Here’s What Lifted Natera (NTRA) in Q4 and 2024

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
NTRA

StockStory

3 months ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?
NTRA

Insider Monkey

3 months ago

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?

NTRA

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 03/17/2025

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value
NTRA

Simply Wall St.

4 months ago

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value

Exploring Three High Growth Tech Stocks In The US Market
NTRA

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks In The US Market

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board
NTRA

Simply Wall St.

4 months ago

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Why Is Natera (NTRA) Stock Soaring Today
NTRA

StockStory

4 months ago

Why Is Natera (NTRA) Stock Soaring Today

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
NTRA

Business Wire

4 months ago

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say
NTRA

Zacks

4 months ago

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say

NTRA

MT Newswires

4 months ago

Natera Set to Continue Upside Surprises During 2025, Beyond, Morgan Stanley Says

NTRA

MT Newswires

4 months ago

Natera Granted US Patent for Testing Single Nucleotide Variants

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD
NTRA

Business Wire

4 months ago

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD

Natera Full Year 2024 Earnings: Beats Expectations
NTRA

Simply Wall St.

4 months ago

Natera Full Year 2024 Earnings: Beats Expectations

Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
NTRA

Simply Wall St.

4 months ago

Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

NTRA

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Natera Inc Earnings Call

Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements
NTRA

GuruFocus.com

4 months ago

Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates
NTRA

Zacks

4 months ago

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales
NTRA

StockStory

4 months ago

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales

Natera Reports Fourth Quarter and Full Year 2024 Financial Results
NTRA

Business Wire

4 months ago

Natera Reports Fourth Quarter and Full Year 2024 Financial Results

Natera (NTRA) Q4 Earnings: What To Expect
NTRA

StockStory

4 months ago

Natera (NTRA) Q4 Earnings: What To Expect

Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect
NTRA

GuruFocus.com

4 months ago

Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect

NTRA

MT Newswires

4 months ago

Natera's Signatera Lung Cancer Test Meets Medicare Coverage Requirements

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
NTRA

Business Wire

4 months ago

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer

Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio
NTRA

Insider Monkey

4 months ago

Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio

Natera (NTRA) Surged on Blowout Quarterly Results
NTRA

Insider Monkey

4 months ago

Natera (NTRA) Surged on Blowout Quarterly Results

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
NTRA

Business Wire

4 months ago

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025

Schrodinger Stock Scores IBD Rating Upgrade
NTRA

Investor's Business Daily

5 months ago

Schrodinger Stock Scores IBD Rating Upgrade

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
NTRA

Business Wire

5 months ago

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

High Growth Tech Stocks to Watch in February 2025
NTRA

Simply Wall St.

5 months ago

High Growth Tech Stocks to Watch in February 2025

Natera Announces National Commercial Coverage for its Fetal RhD NIPT
NTRA

Business Wire

5 months ago

Natera Announces National Commercial Coverage for its Fetal RhD NIPT

Here’s Why Natera (NTRA) Surged in Q4
NTRA

Insider Monkey

5 months ago

Here’s Why Natera (NTRA) Surged in Q4

Natera reports new data from Phase III study of colorectal cancer detection test
NTRA

Medical Device Network

5 months ago

Natera reports new data from Phase III study of colorectal cancer detection test

Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
NTRA

Business Wire

5 months ago

Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer

Natera to Present New Data at the 2025 ASCO GI Symposium
NTRA

Business Wire

5 months ago

Natera to Present New Data at the 2025 ASCO GI Symposium

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
NTRA

Investor's Business Daily

5 months ago

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone

Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
NTRA

Business Wire

6 months ago

Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'
NTRA

Investor's Business Daily

6 months ago

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
NTRA

Business Wire

6 months ago

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection

Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
NTRA

Business Wire

6 months ago

Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
NTRA

Motley Fool

6 months ago

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings

Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
NTRA

Business Wire

6 months ago

Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Six IBD 50 Stocks Bear Gifts Even As Santa Claus Rally Fizzles
NTRA

Investor's Business Daily

6 months ago

Six IBD 50 Stocks Bear Gifts Even As Santa Claus Rally Fizzles

High Growth Tech Stocks To Watch In January 2025
NTRA

Simply Wall St.

6 months ago

High Growth Tech Stocks To Watch In January 2025

3 US Stocks That May Be Trading At A Discount
NTRA

Simply Wall St.

6 months ago

3 US Stocks That May Be Trading At A Discount

Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years
NTRA

Simply Wall St.

6 months ago

Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years

Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy?
NTRA

Zacks

7 months ago

Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy?

NTRA

MT Newswires

7 months ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
NTRA

Business Wire

7 months ago

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics

What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller?
NTRA

Insider Monkey

7 months ago

What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller?

Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer
NTRA

TipRanks

7 months ago

Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer

Share on Social Networks: